Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Int J Pharm Pract ; 32(5): 355-362, 2024 Sep 03.
Artículo en Inglés | MEDLINE | ID: mdl-38965914

RESUMEN

OBJECTIVES: This study aimed to investigate and provide insight into the prevalence and patterns of off-label drug use in the pediatric population from the perspective of community pharmacists, addressing the existing data gap in a developing setting. METHODS: A questionnaire-based cross-sectional study was conducted on Albanian community pharmacists in June 2021. The online administered survey explored the participants' demographic details, perceptions, and experiences with off-label prescriptions in pediatric patients. The statistical analysis conducted on the survey data comprised the construction of frequency tables and the application of the chi-square test for independence. KEY FINDINGS: Three hundred and thirty-six community pharmacists nationwide completed the survey, out of which 186 (55.3%) were practiced in Tirana, the capital of Albania. Over 80% of surveyed pharmacists (n = 275) had encountered off-label drug prescriptions in pediatric patients, yet only 40% of participants reported dispensing medicines for off-label use. Community pharmacists reported that general pediatricians tended to prescribe off-label medications more frequently than pediatric subspecialists or general practitioners. It was found that off-label prescriptions were more frequently observed among children aged between 2 and 11 years. Antibiotics were the most reported medicines for off-label use in this study mentioned in almost all off-label categories. CONCLUSIONS: Prescribing medicines for unapproved uses for the treatment of pediatric patients is present in community settings in Albania. This indicates the need for further data collection and analysis to understand off-label practices in our country's pediatric population comprehensively.


Asunto(s)
Servicios Comunitarios de Farmacia , Uso Fuera de lo Indicado , Farmacéuticos , Humanos , Uso Fuera de lo Indicado/estadística & datos numéricos , Estudios Transversales , Masculino , Femenino , Farmacéuticos/estadística & datos numéricos , Farmacéuticos/organización & administración , Niño , Adulto , Servicios Comunitarios de Farmacia/estadística & datos numéricos , Servicios Comunitarios de Farmacia/organización & administración , Encuestas y Cuestionarios , Preescolar , Persona de Mediana Edad , Pautas de la Práctica Farmacéutica/estadística & datos numéricos , Actitud del Personal de Salud , Adolescente , Percepción , Adulto Joven
3.
Int J Pharm ; 473(1-2): 536-44, 2014 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-25064728

RESUMEN

The purpose of this study was to investigate the effect of pH and method of crystallization on the solid physical form of indomethacin (IDM). IDM, a non steroidal anti-inflammatory drug poorly soluble in water, underwent two different crystallization methods: crystallization by solvent evaporation under reduced pressure at 50.0°C (method A), and crystallization by cooling of solution from 50.0 to 5.0°C (method B). In both cases, several aqueous ethanolic solutions of IDM of different pHs were prepared. pHs were adjusted by adding acidic solutions (HCl 2M) or alkali (NaOH or NH4OH 2M) to an aqueous ethanolic solution of IDM. Thus, several batches were recovered after crystallization. The chemical stability of IDM was verified through (1)H NMR and mass spectroscopy (FIA-ESI-MS), that revealed that IDM degraded in strong alkali media (pH ≥ 12). Crystals obtained under different crystallization conditions at pHs of 1.0, 4.5, 7.0, 8.0, 10.0 and chemically stable were thus characterized for crystal habit by scanning electron microscopy, for thermal behaviour by differential scanning calorimetry, and thermogravimetry, and for solid state by X-ray powder diffractometry. Under the Method A, IDM always crystallized into pure metastable alpha form when solutions were acidified or alkalized respectively with HCl and NH4OH. On the contrary, in presence of NaOH, IDM crystallized under a mixture of alpha and sodium trihydrate form, because the presence of the sodium counter ion orientates the crystallization towards the formation of the trihydrate salt. Under the method B, at pH of 1.0, IDM crystallized under the alpha form; at pH 4.5, IDM crystallized under the form alpha in presence of some nuclei of gamma form; at pH 7.0, 8.0, and 10.0 for NH4OH, IDM crystallized under the most stable polymorph gamma form, whereas in presence of NaOH, a mix of alpha, and salt forms was formed whatever the pH of the solution.


Asunto(s)
Antiinflamatorios no Esteroideos/química , Indometacina/química , Rastreo Diferencial de Calorimetría , Química Farmacéutica , Cristalización , Calor , Concentración de Iones de Hidrógeno , Microscopía Electrónica de Rastreo , Difracción de Polvo , Presión , Soluciones , Termogravimetría , Difracción de Rayos X
4.
Int J Clin Pharm ; 35(3): 323-6, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23423641

RESUMEN

BACKGROUND: There is little evidence on benzodiazepine misuse and associated factors in transitional countries of the Western Balkans. OBJECTIVE: The aim of this study was to assess the level and socioeconomic correlates of misuse of benzodiazepine drugs in the Albanian adult population. METHOD: We conducted a cross-sectional study including a representative sample of 422 individuals (158 men and 264 women) who were benzodiazepines users. A structured questionnaire included data on age, gender, type of drug used, and awareness of possibility to develop dependence and continuation of therapy after prescription. RESULTS: 289 individuals reported treatment continuation compared with 89 participants who reported no continuation of benzodiazepine drugs. There were no significant age group (P = 0.351), sex (P = 0.454), or educational differences (P = 0.117) in treatment continuation. Age was inversely related to the awareness of becoming dependent with the prolonged use of benzodiazepines (78.4% of the persons aged ≤40 years were aware of the dependence versus 51.9% in the age group >40 years; P = 0.002). CONCLUSION: Our study provides pioneering evidence on the use and misuse of benzodiazepines in Albania. Findings from this study may influence the reforms and policy formulation related to drug misuse in Albania.


Asunto(s)
Benzodiazepinas/efectos adversos , Conocimientos, Actitudes y Práctica en Salud , Trastornos Relacionados con Sustancias/epidemiología , Adulto , Factores de Edad , Albania/epidemiología , Benzodiazepinas/administración & dosificación , Estudios Transversales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Factores Socioeconómicos , Encuestas y Cuestionarios
5.
Drug Dev Ind Pharm ; 38(9): 1128-33, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22188183

RESUMEN

A microemulsion for the cutaneous release of quercetin was prepared. An aqueous phase, containing 40% Transcutol® P as solubilizing agent and permeation enhancer, was emulsified with Labrafil® as oil phase and Labrasol®/Capryol™ 90 as Solvent/Co-solvent. Quercetin was dissolved in the microemulsion at the concentration of 1%. Ternary phase diagrams were generated to determine the optimal concentration of each excipient composing the microemulsion. The physicochemical properties of the microemulsion, such as pH, viscosity, refractive index, and particle size distribution were determined. The microemulsion was stable for 12 months at the storing conditions of 25.0 ± 1.0°C. The in vitro quercetin permeability into and through the abdominal hairless pig skin was determined by vertical Franz's cells. Quercetin showed hardly any permeability through the skin when dissolved in water- and Transcutol® P-free media, whereas a remarkable increase in cutaneous permeability was observed when quercetin was formulated in the microemulsion or when simply dissolved in Transcutol® P. These two last formulations are those showing the lower skin retention.


Asunto(s)
Antioxidantes/metabolismo , Emulsionantes/química , Glicoles de Etileno/química , Excipientes/química , Quercetina/metabolismo , Piel/química , Administración Cutánea , Animales , Antioxidantes/administración & dosificación , Antioxidantes/química , Química Farmacéutica , Fármacos Dermatológicos/administración & dosificación , Fármacos Dermatológicos/química , Fármacos Dermatológicos/metabolismo , Difusión , Estabilidad de Medicamentos , Emulsiones , Concentración de Iones de Hidrógeno , Técnicas In Vitro , Cinética , Tamaño de la Partícula , Permeabilidad , Quercetina/administración & dosificación , Quercetina/química , Piel/efectos de los fármacos , Solubilidad , Sus scrofa , Viscosidad
6.
J Pharm Biomed Anal ; 47(2): 422-8, 2008 Jun 09.
Artículo en Inglés | MEDLINE | ID: mdl-18295427

RESUMEN

The aim of this work was to develop and validate a method to assess the dissolution behaviour of rociverine sugar-coated tablets. In our laboratories, an HPLC-MS in reverse phase method of analysis was developed for the dosage of unknown rociverine solution. This analytical method was applied to determine the dissolution rate of rociverine tablets produced by the industrial procedure, because there is no official method description. Dissolution tests were carried out in sink conditions as follows: dissolution medium HCl 0.01 N, paddle rotation speed 50 rpm and vessel volume 1000 ml. The dissolution test gave satisfactory results: 95% of the drug was dissolved within 30 min and drug dissolution was concluded after 60 min. The method was demonstrated to be adequate for Quality Control of rociverine tablets. Validation was inferred from specificity, linearity, precision, accuracy and robustness.


Asunto(s)
Cromatografía Líquida de Alta Presión/métodos , Ácidos Ciclohexanocarboxílicos/análisis , Espectrometría de Masas/métodos , Parasimpatolíticos/análisis , Comprimidos/química , Ácidos Ciclohexanocarboxílicos/química , Ácidos Ciclohexanocarboxílicos/farmacocinética , Ácido Clorhídrico/química , Parasimpatolíticos/química , Reproducibilidad de los Resultados , Solubilidad , Comprimidos Recubiertos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA